Mentice AB (publ) (STO:MNTC)

Market Cap	359.24M
Revenue (ttm)	263.95M
Net Income (ttm)	-56.10M
Shares Out	25.57M
EPS (ttm)	-2.19
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,065
Average Volume	8,097
Open	13.85
Previous Close	13.95
Day's Range	13.50 - 14.55
52-Week Range	12.35 - 31.50
Beta	0.67
RSI	42.54
Earnings Date	Jul 24, 2025

About Accolade

Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology in Europe, the Middle East, Africa, the Asia Pacific, and the Americas. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedural learning models; patient simulator accessories and extensions for endovascular...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 131
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MNTC

Financial Performance

In 2024, Mentice AB's revenue was 291.81 million, an increase of 6.07% compared to the previous year's 275.12 million. Losses were -18.42 million, 553.9% more than in 2023.